Version 1.0 — Published February 2026
Quick Answer
Myocardial infarction contributes 2–4 direct questions per NEET PG paper. Master these 10 high-yield areas:
- STEMI vs NSTEMI — STEMI is full-thickness necrosis with ST-elevation >=1 mm in 2 contiguous leads; NSTEMI is subendocardial with ST-depression or T-inversion. Both have positive troponin.
- Pathophysiology — Atherosclerotic plaque rupture → platelet aggregation → thrombus → coronary occlusion → myocardial necrosis within 20 minutes
- ECG localization — II/III/aVF = inferior/RCA; V1–V2 = septal/proximal LAD; V3–V4 = anterior/mid-LAD; V5–V6, I, aVL = lateral/LCx; ST-depression V1–V3 = posterior (mirror)
- Cardiac enzymes — Troponin (3–6 hr rise, 24 hr peak, 7–14 day duration, gold standard), CK-MB (4–6 hr rise, 48–72 hr duration, useful for re-infarction), myoglobin (1–2 hr rise, nonspecific)
- MONA-BASH — Morphine, Oxygen (if SpO2 <90%), Nitrates, Aspirin 325 mg chewed, Beta-blocker, ACE inhibitor, Statin high-intensity, Heparin
- Fibrinolytics — Alteplase (tPA, fibrin-specific, preferred), streptokinase (cheaper, allergenic, one-time use), tenecteplase (single bolus). Window: within 12 hours of symptom onset
- PCI window — Door-to-balloon <=90 minutes at PCI-capable center, door-to-device <=120 minutes with transfer; primary PCI superior to fibrinolysis
- Mechanical complications — LV free wall rupture (3–5 days, most fatal), VSR (new murmur + shock), papillary muscle rupture (acute severe MR, inferior MI)
- Arrhythmic complications — VF (leading cause of sudden death, first hour), AV block (inferior MI), accelerated idioventricular rhythm (reperfusion marker, benign)
- Secondary prevention (ABCDE) — Aspirin + P2Y12 inhibitor (DAPT 12 months), Beta-blocker, high-intensity Statin (LDL <70 mg/dL), Diet + Diabetes control, Exercise + ACE inhibitor if LVEF <40%
Myocardial infarction is irreversible necrosis of heart muscle caused by prolonged ischemia — and it sits at the intersection of medicine, pharmacology, and emergency care in NEET PG. The student who masters STEMI/NSTEMI differentiation, ECG territory mapping, and fibrinolytic selection has covered the foundation for 2–4 marks across papers. Pair this guide with daily MCQ practice on the Medicine subject hub and cross-reference the high-yield medicine topics overview for context on how ischemic heart disease fits into the broader cardiology testing pattern.
Types of MI — STEMI vs NSTEMI
Myocardial infarction is the acute death of myocardial tissue from prolonged coronary ischemia, classified by ECG appearance and depth of necrosis.
| Feature | STEMI | NSTEMI |
|---|
| ECG | ST-elevation >=1 mm in 2 contiguous leads; new LBBB | ST-depression or T-wave inversion |
| Coronary occlusion | Complete | Partial / intermittent |
| Necrosis depth | Transmural (full thickness) | Subendocardial |
| Troponin | Positive | Positive |
| Urgent reperfusion | Primary PCI or fibrinolysis within 12 hr | Risk-stratified PCI within 24–72 hr |
| Plaque morphology | Ruptured plaque + occlusive red thrombus | Eroded plaque + non-occlusive white thrombus |
Universal MI definition (4th Universal Definition, 2018): Detection of a rise and/or fall of cardiac troponin with at least one value above the 99th percentile upper reference limit, PLUS one of: ischemic symptoms, new ischemic ECG changes, new pathological Q waves, imaging evidence of new loss of viable myocardium, or identification of coronary thrombus on angiography/autopsy.
Unstable angina vs NSTEMI: Both show ischemic ECG changes and ischemic chest pain at rest. The discriminator is troponin — positive = NSTEMI, negative = unstable angina.
Pathophysiology of acute MI
Atherosclerotic plaque rupture is the initiating event in 90% of acute coronary syndromes. The sequence is predictable and testable.
Stepwise pathogenesis:
- Fatty streak (foam cells, LDL oxidation) — begins in second decade
- Fibrous plaque (smooth muscle proliferation + collagen cap)
- Vulnerable plaque — thin fibrous cap (<65 microns), large lipid core, macrophage infiltration
- Plaque rupture — triggered by shear stress, catecholamine surge (morning peak 6 AM–12 PM)
- Platelet adhesion and aggregation — exposed collagen + tissue factor
- Thrombus formation — platelet-rich white thrombus → fibrin-rich red thrombus
- Coronary occlusion — complete (STEMI) or partial (NSTEMI/UA)
- Myocardial necrosis — begins within 20 minutes, complete by 6 hours
Wavefront of necrosis (Reimer and Jennings): Necrosis begins at the subendocardium and spreads outward to the epicardium over 6 hours. This is the rationale for the "time is muscle" principle — earlier reperfusion salvages more myocardium.
NEET PG trap: The posteromedial papillary muscle has a single blood supply (from posterior descending artery, usually an RCA branch), making it the most commonly ruptured papillary muscle in inferior MI. The anterolateral papillary muscle has dual supply (LAD + LCx) and is rarely affected.
ECG localization — matching leads to coronary artery
ECG localization is the systematic correlation of ST-elevation patterns with the occluded coronary artery — the single most testable ECG concept in NEET PG.
| Wall | Leads | Artery | Reciprocal changes |
|---|
| Inferior | II, III, aVF | RCA (80%) or LCx (20%) | ST-depression in I, aVL |
| Septal | V1, V2 | Proximal LAD | — |
| Anterior | V3, V4 | Mid LAD | — |
| Anteroseptal | V1–V4 | Proximal/mid LAD | ST-depression in II, III, aVF |
| Lateral | V5, V6, I, aVL | Left circumflex or diagonal branch | ST-depression in III, aVF |
| Anterolateral | V3–V6, I, aVL | Proximal LAD | — |
| Posterior | ST-depression V1–V3 (mirror) or ST-elevation V7–V9 | RCA or LCx | Tall R in V1 |
| Right ventricular | ST-elevation V4R (right-sided lead) | Proximal RCA | Seen with 30–50% of inferior MIs |
High-yield points:
- Inferior MI + RV involvement: Avoid nitrates and morphine (preload-dependent — can cause profound hypotension). Treat with IV fluid challenge.
- Anterior MI: Worst prognosis because of largest myocardial territory and highest risk of cardiogenic shock
- LBBB with ischemic symptoms: Treat as STEMI equivalent. Sgarbossa criteria help identify MI in pre-existing LBBB
- Wellens syndrome: Biphasic T-waves in V2–V3 = critical proximal LAD stenosis (not yet occluded — pre-infarction)
- de Winter T-waves: Upsloping ST-depression with tall T-waves in V1–V6 = proximal LAD occlusion equivalent
Cardiac enzymes — timeline and interpretation
Cardiac biomarkers are proteins released into blood from necrotic myocytes, and their time-course is a predictable NEET PG topic.
| Marker | Rise | Peak | Duration | Clinical use |
|---|
| Myoglobin | 1–2 hr | 6–8 hr | 24 hr | Early but nonspecific (skeletal muscle) |
| CK-MB | 4–6 hr | 24 hr | 48–72 hr | Re-infarction detection |
| Troponin I / T | 3–6 hr | 24 hr | 7–14 days | Gold standard for diagnosis |
| High-sensitivity troponin | 1–3 hr | 12 hr | 7–14 days | Rapid rule-in/rule-out (0/1 hr algorithm) |
| LDH | 24–48 hr | 3–6 days | 10–14 days | Obsolete (historical use) |
| AST (SGOT) | 6–12 hr | 24 hr | 3–5 days | Obsolete |
Key exam points:
- Troponin: Most sensitive AND most specific cardiac marker. Cardiac-specific isoforms (cTnI, cTnT) are not present in skeletal muscle.
- CK-MB: Useful for diagnosing re-infarction (troponin remains elevated for 2 weeks; CK-MB normalizes in 3 days, so a new CK-MB rise indicates re-infarction)
- Myoglobin: Earliest to rise but not cardiac-specific — elevated in rhabdomyolysis, IM injections, renal failure
- False-positive troponin: Pulmonary embolism, myocarditis, sepsis, CKD, heart failure, aortic dissection
Practical interpretation: A patient presenting 1 hour after chest pain onset may have a normal initial troponin. Repeat at 3 and 6 hours. High-sensitivity troponin enables a 0/1 hour algorithm — negative at both time points rules out MI with 99% sensitivity.
Initial management — MONA-BASH
Initial STEMI management is the first-hour bundle of interventions that stabilize the patient and prepare for reperfusion.
MONA-BASH (modified 2022 ACC-AHA):
- Morphine — 2–4 mg IV for unrelieved chest pain. Used selectively (CRUSADE data suggest increased mortality if given routinely). Avoid in RV infarction.
- Oxygen — Only if SpO2 <90% or respiratory distress. Routine oxygen in normoxic patients increases infarct size (AVOID-trial).
- Nitrates — Sublingual nitroglycerin 0.4 mg every 5 minutes (up to 3 doses), then IV. Avoid in RV infarct, severe aortic stenosis, and PDE-5 inhibitor use within 24 hours.
- Aspirin — 162–325 mg chewed on arrival. Reduces mortality by 23% (ISIS-2 trial). Continued lifelong at 75–100 mg.
- Beta-blocker — Oral metoprolol within 24 hours if no contraindication. Avoid if signs of heart failure, cardiogenic shock, bradycardia, or Killip class >=II (COMMIT trial).
- ACE inhibitor — Start within 24 hours, especially if anterior MI, LVEF <40%, or hypertension. ARB if ACE intolerant.
- Statin — High-intensity (atorvastatin 80 mg or rosuvastatin 40 mg). Start early, continue lifelong. LDL target <70 mg/dL (2019 ESC) or <55 mg/dL (very high risk).
- Heparin — Unfractionated heparin 60 U/kg bolus + 12 U/kg/hr infusion, or enoxaparin 1 mg/kg BD. Mandatory with PCI or fibrinolysis.
Antiplatelet loading: Add a P2Y12 inhibitor — ticagrelor 180 mg, prasugrel 60 mg, or clopidogrel 300–600 mg — alongside aspirin for dual antiplatelet therapy (DAPT).
Fibrinolytic therapy
Fibrinolysis is the pharmacological dissolution of coronary thrombus using plasminogen activators — the reperfusion strategy when primary PCI is not available within 120 minutes.
| Agent | Type | Dose | Specificity | Notes |
|---|
| Streptokinase | Non-fibrin specific | 1.5 million U IV over 60 min | Low | Allergenic, hypotension, one-time use only |
| Alteplase (tPA) | Fibrin-specific | 15 mg bolus + 50 mg over 30 min + 35 mg over 60 min | High | Preferred in pregnancy (no transplacental transfer) |
| Reteplase (rPA) | Fibrin-specific | 10 U bolus x 2 (30 min apart) | High | Longer half-life |
| Tenecteplase (TNK-tPA) | Fibrin-specific | Single weight-based IV bolus | Highest | Most convenient; preferred pre-hospital |
Indications: STEMI within 12 hours of symptom onset when primary PCI cannot be performed within 120 minutes.
Absolute contraindications:
- Any prior intracranial hemorrhage
- Known intracranial neoplasm, AVM, or aneurysm
- Ischemic stroke within 3 months (except within 4.5 hours for acute stroke thrombolysis)
- Suspected aortic dissection
- Active bleeding or bleeding diathesis
- Significant closed head/facial trauma within 3 months
- Prior streptokinase use within 6 months (streptokinase only)
Relative contraindications: Uncontrolled HTN (>180/110 mmHg), oral anticoagulant therapy, pregnancy, active peptic ulcer, traumatic or prolonged CPR (>10 minutes), non-compressible vascular puncture.
Door-to-needle time: Fibrinolysis should be initiated within 30 minutes of hospital arrival.
Success markers: Resolution of chest pain, >=50% ST-segment resolution at 60–90 minutes, reperfusion arrhythmias (accelerated idioventricular rhythm).
Primary PCI — the reperfusion gold standard
Primary percutaneous coronary intervention is mechanical revascularization with balloon angioplasty and stent placement — superior to fibrinolysis when available within the time window.
Time windows:
- Door-to-balloon time: <=90 minutes at a PCI-capable center
- Door-to-device time: <=120 minutes if transfer from non-PCI center
- Symptom-to-balloon time: Ideally <=2 hours; fibrinolysis preferred if PCI delay >120 minutes beyond the time fibrinolysis could have been started
PCI superiority (PRIMARY trial, meta-analyses):
- Lower mortality (reduction of 2–3% absolute)
- Lower re-infarction rate
- Lower intracranial hemorrhage rate (<1% vs 1–2% for fibrinolysis)
- Better long-term LV function
Stent types:
- Drug-eluting stents (DES): First-line (everolimus, zotarolimus, sirolimus coated). Require DAPT for 12 months minimum.
- Bare-metal stents (BMS): Used when short DAPT duration needed (e.g., high bleeding risk, upcoming surgery). DAPT 1 month only.
Rescue PCI: Performed when fibrinolysis fails (<50% ST resolution at 60–90 min, persistent chest pain, hemodynamic instability).
Pharmaco-invasive strategy: Fibrinolysis followed by routine angiography and PCI within 2–24 hours. Improves outcomes compared to fibrinolysis alone.
Complications of MI
Post-MI complications are categorized by mechanism — mechanical, arrhythmic, embolic, pericardial, and inflammatory — each with a characteristic time course.
Mechanical complications
| Complication | Timing | Presentation | Management |
|---|
| LV free wall rupture | 3–5 days | Sudden hemodynamic collapse, electromechanical dissociation, tamponade | Emergency pericardiocentesis + surgical repair (mortality >80%) |
| Ventricular septal rupture | 3–5 days | New harsh holosystolic murmur at LSB + shock + oxygen step-up at RV | IABP + emergency surgical repair |
| Papillary muscle rupture | 2–7 days | Acute severe MR, pulmonary edema, soft systolic murmur | IABP + emergency mitral valve replacement |
| Ventricular aneurysm | Weeks to months | Persistent ST-elevation >6 weeks, heart failure, thrombus | Anticoagulation; surgical repair if refractory |
| Cardiogenic shock | Hours to days | SBP <90, signs of hypoperfusion, LVEF typically <30% | Revascularization (SHOCK trial) + inotropes + mechanical support |
Arrhythmic complications
- Ventricular fibrillation: Leading cause of sudden death in first hour. Treat with immediate defibrillation.
- Ventricular tachycardia: Sustained monomorphic VT in late MI (days to weeks) indicates scar-related re-entry — ICD indication.
- Atrial fibrillation: 10–20% of MIs. Rate control with beta-blocker; anticoagulation if CHA2DS2-VASc indicates.
- AV block: Inferior MI causes AV nodal block (narrow QRS, often transient, atropine-responsive). Anterior MI causes infranodal block (wide QRS, high mortality, pacemaker indication).
- Accelerated idioventricular rhythm (AIVR): Rate 60–110, occurs with reperfusion — benign, no treatment needed.
Embolic and pericardial complications
- Mural thrombus: 20–30% of anterior MIs. Treat with anticoagulation for 3 months if LV thrombus on echo.
- Peri-infarction pericarditis: Days 2–4, pleuritic chest pain, friction rub. Treat with high-dose aspirin (avoid NSAIDs other than aspirin — impair healing).
- Dressler syndrome: Weeks 2–10, autoimmune pericarditis + fever + pericardial effusion + pleural effusion. Treat with aspirin or colchicine.
Secondary prevention — the ABCDE approach
Secondary prevention is the lifelong pharmacologic and lifestyle regimen to prevent recurrent cardiovascular events after MI.
The ABCDE regimen:
- A — Antiplatelets + ACE inhibitor:
- Aspirin 75–100 mg lifelong
- P2Y12 inhibitor (ticagrelor preferred, or clopidogrel) for 12 months (DAPT)
- ACE inhibitor (ramipril, lisinopril) — especially if LVEF <40%, anterior MI, diabetes, HTN
- B — Beta-blocker:
- Metoprolol succinate, carvedilol, or bisoprolol
- Reduces mortality by 23% (first 2 years) and prevents sudden death
- Target heart rate 55–60 bpm
- C — Cholesterol lowering:
- High-intensity statin (atorvastatin 80 mg or rosuvastatin 40 mg)
- LDL target <70 mg/dL (or <55 mg/dL very high risk)
- Add ezetimibe or PCSK9 inhibitor (evolocumab, alirocumab) if target not met
- D — Diet and diabetes control:
- Mediterranean diet (PREDIMED trial: 30% relative risk reduction)
- HbA1c target <7%; prefer SGLT2 inhibitors (EMPA-REG) or GLP-1 agonists (LEADER) for diabetic post-MI patients
- E — Exercise, Education, Emotion:
- Cardiac rehabilitation (30 minutes moderate exercise, 5 days/week)
- Smoking cessation (single highest-impact intervention — 36% mortality reduction)
- Screen for depression (30% prevalence post-MI)
DAPT duration:
- 12 months standard
- Extended 30 months if high ischemic risk + low bleeding risk (DAPT score)
- Shortened to 1–3 months if high bleeding risk (MASTER-DAPT)
Eplerenone (mineralocorticoid antagonist): Add if post-MI LVEF <40% plus either diabetes or clinical heart failure (EPHESUS trial).
ICD for primary prevention: Consider at 40 days post-MI if LVEF <=35% despite optimal medical therapy (MADIT-II, SCD-HeFT).
Sources and references
- American College of Cardiology / American Heart Association — 2022 Guideline for the Diagnosis and Management of Patients with STEMI (Circulation, 2022) — the global reference for STEMI protocols and reperfusion windows.
- Harrison's Principles of Internal Medicine, 21st Edition (Loscalzo et al., 2022) — Chapters on Acute Coronary Syndromes and STEMI.
- Braunwald's Heart Disease, 12th Edition (Libby et al., 2022) — detailed pathophysiology and complications of acute MI.
- Thygesen K, Alpert JS, Jaffe AS, et al. — Fourth Universal Definition of Myocardial Infarction (European Heart Journal 2018; 40:237-269).
- ISIS-2 Collaborative Group — Lancet 1988; 332:349-360 — landmark trial establishing aspirin and streptokinase mortality benefit in MI.
- API Textbook of Medicine, 11th Edition (Munjal et al., 2019) — Indian-context management of acute coronary syndromes.
Frequently asked questions
How many MI questions appear in NEET PG?
Myocardial infarction contributes 2-4 direct questions per NEET PG paper across medicine, pharmacology, and emergency medicine. ECG localization to coronary territory, cardiac enzyme timeline, and fibrinolytic contraindications are the three most frequently tested subtopics based on 2019-2025 pattern analysis.
What is the difference between STEMI and NSTEMI?
STEMI shows ST-segment elevation greater than 1 mm in two contiguous leads with complete coronary occlusion and full-thickness myocardial necrosis. NSTEMI shows ST-depression or T-wave inversion with partial occlusion and subendocardial necrosis. Both have positive troponin, but only STEMI qualifies for emergency fibrinolysis or primary PCI within 90 minutes.
Which ECG leads correspond to which coronary artery?
Leads II, III, aVF indicate inferior wall and right coronary artery (RCA). V1-V2 indicate septal and proximal LAD. V3-V4 indicate anterior wall and mid-LAD. V5-V6, I, aVL indicate lateral wall and left circumflex. V7-V9 with ST-depression in V1-V3 indicates posterior wall. This mapping is the single most tested ECG concept in NEET PG.
What is the time course of cardiac enzymes in MI?
Troponin I and T rise at 3-6 hours, peak at 24 hours, and stay elevated for 7-14 days. CK-MB rises at 4-6 hours, peaks at 24 hours, and normalizes by 48-72 hours. Myoglobin rises earliest at 1-2 hours but lacks specificity. Troponin is the gold standard marker for both diagnosis and re-infarction detection.
What is MONA-BASH in MI management?
MONA-BASH is the mnemonic for initial STEMI management: Morphine, Oxygen (only if SpO2 less than 90 percent), Nitrates, Aspirin 325 mg chewed, Beta-blocker, ACE inhibitor, Statin (high-intensity atorvastatin 80 mg), Heparin. Morphine and oxygen are now used selectively, not routinely, based on updated 2022 ACC-AHA guidelines.
What is the door-to-balloon time for primary PCI?
Door-to-balloon time should be under 90 minutes for STEMI patients presenting directly to a PCI-capable center. If transfer from a non-PCI center is required, door-to-device time extends to 120 minutes. If primary PCI cannot be achieved within these windows, fibrinolysis should be initiated within 30 minutes of hospital arrival (door-to-needle time).
What are absolute contraindications to fibrinolysis?
Absolute contraindications include any prior intracranial hemorrhage, known intracranial malignancy or AVM, ischemic stroke within 3 months, active bleeding or bleeding diathesis, suspected aortic dissection, significant closed head trauma within 3 months, and for streptokinase specifically, prior use within 6 months. Uncontrolled hypertension greater than 180/110 mmHg is a relative contraindication.
What is the most common mechanical complication of MI?
Left ventricular free wall rupture is the most common fatal mechanical complication (3-5 days post-MI), usually in elderly women with first large anterior MI. Ventricular septal rupture presents with new harsh holosystolic murmur and hemodynamic collapse. Papillary muscle rupture causes acute severe mitral regurgitation, most often with inferior MI affecting the posteromedial papillary muscle (single blood supply from PDA).
What is the secondary prevention regimen after MI?
Secondary prevention requires five lifelong classes (ABCDE): Aspirin plus a P2Y12 inhibitor (DAPT for 12 months, then aspirin alone), Beta-blocker (metoprolol or carvedilol), Cholesterol lowering with high-intensity statin (atorvastatin 80 mg or rosuvastatin 40 mg, LDL target under 70 mg/dL), Diet and diabetes control, Exercise and ACE inhibitor (especially if LVEF under 40 percent).
Which arrhythmia is the leading cause of early death in MI?
Ventricular fibrillation is the leading cause of sudden death in the first hour after MI, before the patient reaches hospital. In-hospital, primary VF incidence peaks in the first 4 hours. Prompt defibrillation is the only effective treatment. Reperfusion arrhythmias (accelerated idioventricular rhythm) are benign markers of successful thrombolysis and do not require treatment.
Ready to test your MI knowledge? Convert this guide into exam marks with active MCQ recall — cross-link to congenital heart diseases for NEET PG for the adjacent cardiology territory and use the AI tutor to drill ECG interpretation on demand.
Start practicing cardiology MCQs free →
Explore our pricing plans for unlimited practice across all 19 subjects, AI-powered doubt resolution, and personalized study plans.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Written by: NEETPGAI Editorial Team
Reviewed by: Pending SME Review
Last reviewed: February 2026
This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.
